Renaissance Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,982	Closed	-$422K	–	267
2018 Q4	$422K	Buy	4,982 +1,622	+48%	+$137K	0.02%	220
2018 Q3	$575K	Buy	+3,360	New	+$575K	0.02%	207